Improving outcome in acute coronary syndromes â as good as it gets?
European Heart Journal, Purcell, H., Fox, K.M.
Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial.
European Heart Journal, Fox, K.A.A.
Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients.
European Heart Journal, Colombo, A.
5 , Heeschen C, Goldmann B. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina ...
European Heart Journal, Wallentin, L.
Plant lipids that lower serum cholesterol
European Heart Journal, Thompson, G.R.
Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular dysfunction: a retrospective ...
European Heart Journal, Lip, G.Y.H.
Unstable angina: the breakthrough
European Heart Journal, Hamm, C.W.
Depression and heart failure â not yet a target for therapy?
European Heart Journal, Cleland, J.G.F., Wang, M.
Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q ...
European Heart Journal, The Frax.I.S. Study Group
In adulthood, the reactivity of different pulmonary arterial segments varies. [...]we investigated the presence of endothelial heterogeneity in perinatal porcine pulmonary arteries and compared it ...
Cardiovascular Research, Boels, P.J., Deutsch, J., Gao, B., Haworth, S.G.